Heart Test Laboratories Inc. (HSCS) Peer Comparison
$3.36
$0.35
(11.63%)
As on 03-Sep-2026 16:26EDT
Market cap
$14 Mln
Revenue (TTM)
$90 Mln
P/E Ratio
--
P/B Ratio
62.8
Div. Yield
0 %
Edit
| Heart Test Laboratories Inc. (HSCS) | Neogen (NEOG) | AngioDynamics (ANGO) | Nutriband Inc (NTRB) | Accuray (ARAY) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
14 | 2,543 | 655 | 54 | 33 |
Revenue ($ Mln) |
-- | 870 | 320 | 2 | 402 |
Net Profit ($ Mln) |
-9.14 | -7.90 | -36.74 | -8.08 | -49.19 |
Net Margin (%) |
-10.21 | -0.91 | -11.48 | -448.39 | -12.24 |
RoE (%) |
-8.10 | -0.38 | -20.77 | -119.40 | -80.08 |
Price to Earnings |
-- | -- | -- | -- | -- |
Price-To-Book |
62.84 | 1.22 | 3.82 | 9.50 | 0.75 |
Income Statement ($ Mln)
| Heart Test Laboratories Inc. (HSCS) | Neogen (NEOG) | AngioDynamics (ANGO) | Nutriband Inc (NTRB) | Accuray (ARAY) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
0.00 | 870.40 | 320.17 | 2.04 | 401.95 |
|
Cost of Revenue
|
0.13 | 461.90 | 145.28 | 1.47 | 290.49 |
|
Gross Profit
|
-0.13 | 408.50 | 174.89 | 0.57 | 111.45 |
|
Operating Expenses
|
8.28 | 430.10 | 214.82 | 8.88 | 137.90 |
|
Operating Profit (EBIT)
|
-8.41 | -21.60 | -39.93 | -8.32 | -26.44 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
-9.14 | -9.00 | -36.30 | -8.23 | -47.25 |
|
Provision for Tax
|
-3.68 | -1.10 | 0.44 | -- | 1.95 |
|
Profit after Tax (Net Income)
|
-9.14 | -7.90 | -36.74 | -8.23 | -49.19 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | -- | -- | -- | -- |
Liabilities ($ Mln)
| Heart Test Laboratories Inc. (HSCS) | Neogen (NEOG) | AngioDynamics (ANGO) | Nutriband Inc (NTRB) | Accuray (ARAY) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
225.53 | 2,092.90 | 170.83 | 6.68 | 41.70 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
175.50 | 1,094.90 | 21.62 | 0.08 | 210.57 |
|
Current Liabilities
|
4,861.11 | 158.20 | 74.72 | 0.78 | 191.41 |
|
Total Liabilities
|
5,262.67 | 3,346.00 | 267.16 | 7.55 | 443.68 |
Assets ($ Mln)
| Heart Test Laboratories Inc. (HSCS) | Neogen (NEOG) | AngioDynamics (ANGO) | Nutriband Inc (NTRB) | Accuray (ARAY) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
2,679.75 | 2,741.40 | 103.77 | 2.56 | 156.18 |
|
Current Assets
|
2,582.93 | 604.60 | 163.39 | 4.99 | 287.50 |
|
Total Assets
|
5,262.14 | 3,346.00 | 267.16 | 7.55 | 443.68 |
|
Total Debt*
|
3,936.65 | 793.70 | -- | 0.25 | 183.87 |
|
Net Current Assets
|
-2.28 | 446.40 | 88.68 | 4.20 | -- |
Cashflow ($ Mln)
| Heart Test Laboratories Inc. (HSCS) | Neogen (NEOG) | AngioDynamics (ANGO) | Nutriband Inc (NTRB) | Accuray (ARAY) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-7.43 | 83.20 | 3.09 | -5.13 | -6.98 |
|
Cash Flow from Investing Activities
|
-0.04 | 70.50 | -5.95 | -0.01 | -12.28 |
|
Cash from Financing Activities
|
8.03 | -99.40 | 0.56 | 5.40 | 6.98 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Heart Test Laboratories Inc. (HSCS) | Neogen (NEOG) | AngioDynamics (ANGO) | Nutriband Inc (NTRB) | Accuray (ARAY) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-0.44 | -0.27 | -20.19 | -121.56 | -20.37 |
|
ROE (%)
|
-8.10 | -0.38 | -20.77 | -125.56 | -80.08 |
|
ROA (%)
|
-0.35 | -0.23 | -13.43 | -109.60 | -10.77 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
-211,666.47 | -0.91 | -11.48 | -404.08 | -12.24 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Heart Test Laboratories Inc. (HSCS) | Neogen (NEOG) | AngioDynamics (ANGO) | Nutriband Inc (NTRB) | Accuray (ARAY) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-0.01 | -0.03 | 0.09 | -0.05 | -0.12 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
-4.30 | 99.28 | -8.09 | 21.50 | -2,992.02 |
|
EPS Growth (%)
|
-- | -- | -- | -- | -26.45 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Heart Test Laboratories Inc. (HSCS) | Neogen (NEOG) | AngioDynamics (ANGO) | Nutriband Inc (NTRB) | Accuray (ARAY) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | -- | -- | -- | -0.64 |
|
Price / Book Value
|
-- | -- | -- | -- | 0.76 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-270.99 | 3.57 | -286.51 | 0.54 | -12.15 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Heart Test Laboratories Inc. (HSCS) | Neogen (NEOG) | AngioDynamics (ANGO) | Nutriband Inc (NTRB) | Accuray (ARAY) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
17.46 | 0.38 | -- | 0.04 | 4.41 |
|
Short term debt to equity ratio
|
16.68 | -- | -- | 0.02 | 0.23 |
|
Current Ratio
|
0.53 | 3.82 | 2.19 | 6.36 | 1.50 |
|
Quick Ratio
|
0.40 | 2.91 | 1.49 | 6.21 | 0.73 |
|
Interest Coverage
|
-21.72 | 0.84 | -75.14 | -364.19 | -- |
Operating Efficiency Ratios
| Heart Test Laboratories Inc. (HSCS) | Neogen (NEOG) | AngioDynamics (ANGO) | Nutriband Inc (NTRB) | Accuray (ARAY) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
0.00 | 16.87 | 15.09 | 5.81 | 16.77 |
|
Asset Turnover
|
0.00 | 0.26 | 1.17 | 0.27 | 0.88 |
|
Receivable days
|
183.94 | 62.98 | 52.17 | 17.24 | 75.09 |
|
Inventory Days
|
900,351.58 | 132.51 | 143.86 | 40.99 | 181.12 |
|
Payable days
|
437,150.98 | 62.75 | 81.46 | 149.23 | 46.89 |
|
Cash Conversion Cycle
|
463,384.53 | 132.75 | 114.57 | -91.00 | 209.32 |
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
